SMMT icon

Summit Therapeutics
SMMT

Overview Fund Activity

203 hedge funds and large institutions have $1.65B invested in Summit Therapeutics in 2024 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 75 increasing their positions, 37 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
203
Holders Change
+37
Holders Change %
+22.29%
% of All Funds
2.7%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
67
Increased
75
Reduced
37
Closed
26
Calls
$36.7M
Puts
$53.9M
Net Calls
-$17.2M
Net Calls Change
+$2.43M

Top Buyers

1
State Street
1
State Street
Massachusetts
$100M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$117M
3
UBS Group
3
UBS Group
Switzerland
$21.2M
4
Millennium Management
4
Millennium Management
New York
$36.6M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$208M

Top Sellers

1
DGM
1
Darwin Global Management
Jersey
$0
2
First Trust Advisors
2
First Trust Advisors
Illinois
$0
3
Citadel Advisors
3
Citadel Advisors
Florida
$3.34M
4
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$643K
5
SCM
5
Soleus Capital Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
FCM
226
Fourpath Capital Management
Oklahoma
– -$6.83K -312 Closed
CPA
227
Capital Performance Advisors
California
– -$788 -36 Closed
S
228
SignatureFD
Georgia
– -$460 -21 Closed
6 7 8 9
10